Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 68.72%54.98M | 178.06%13.54M | 4.30%8.56M | -18.94%7.88M | -33.19%6.54M | -46.40%32.59M | -53.95%4.87M | -50.05%8.2M | -38.03%9.72M | -45.95%9.79M |
| Cost of revenue | 30.01%45.37M | 63.40%10.39M | 14.20%9.13M | -22.10%7.23M | -44.12%6.29M | -48.99%34.9M | 75.70%6.36M | -59.60%7.99M | -55.82%9.29M | -53.05%11.26M |
| Gross profit | 515.75%9.61M | 311.69%3.15M | -372.38%-572K | 48.62%645K | 117.03%250K | 69.61%-2.31M | -121.40%-1.49M | 106.25%210K | 108.14%434K | 74.99%-1.47M |
| Operating expense | -75.49%6.33M | -10.71%19.52M | 1,078.71%6.8M | 57.71%4.1M | -26.24%1.52M | -60.29%25.81M | -60.78%21.86M | -418.66%-695K | -72.81%2.6M | -42.87%2.05M |
| Selling and administrative expenses | 30.56%17.59M | -11.27%3.76M | -35.91%2.09M | 25.47%3.7M | -8.82%2.77M | -32.08%13.48M | -49.57%4.23M | -24.70%3.25M | -10.98%2.95M | -20.22%3.04M |
| -Selling and marketing expense | --0 | --0 | --0 | --0 | --0 | -39.96%80K | -48.24%11K | -28.57%10K | -56.67%13K | -30.88%47K |
| -General and administrative expense | 31.34%17.59M | -11.04%3.76M | -35.71%2.09M | 26.03%3.7M | -7.39%2.77M | -32.02%13.4M | -49.57%4.22M | -24.69%3.24M | -10.56%2.94M | -20.03%2.99M |
| Other operating expenses | -49.97%15.93M | -49.61%15.76M | 11,069.39%5.47M | 4,050.00%1.16M | ---- | -34.54%31.83M | -35.29%31.27M | --49K | -99.55%28K | 59.47%480K |
| Total other operating income | 39.50%27.19M | ---- | -81.09%756K | 101.31%767K | -14.28%1.26M | 462.00%19.49M | 1,272.57%13.65M | -10.26%4M | --381K | 184.82%1.46M |
| Operating profit | 111.67%3.28M | 29.89%-16.37M | -914.81%-7.37M | -59.54%-3.45M | 64.08%-1.27M | 61.26%-28.12M | 52.14%-23.34M | 128.06%905K | 85.46%-2.17M | 62.79%-3.52M |
| Net non-operating interest income (expenses) | 50.39%-705K | 40.51%-94K | 35.45%-122K | 72.84%-132K | 75.51%-144K | 61.29%-1.42M | 81.39%-158K | 80.97%-189K | 49.48%-486K | 32.18%-588K |
| Non-operating interest expense | -50.39%705K | -40.51%94K | -35.45%122K | -72.84%132K | -75.51%144K | -61.29%1.42M | -81.39%158K | -80.97%189K | -49.48%486K | -32.18%588K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -462.32%-1.78M | 96.91%-75K | 463.70%491K | -2.42M | ||||||
| Income from associates and other participating interests | 58.07%-5.49M | 103.45%102K | 58.00%-1.04M | 38.99%-2.71M | 103.31%106K | -375.23%-13.08M | 75.24%-2.96M | -136.63%-2.49M | -248.89%-4.44M | -458.29%-3.2M |
| Special income (charges) | 91.00%-3.32M | 97.05%-1.07M | -94.82%72K | -903.05%-36.83M | -36.29M | -48.92%1.39M | ||||
| Less:Write off | -91.00%3.32M | -97.05%1.07M | ---- | 94.82%-72K | ---- | 903.05%36.83M | --36.29M | ---- | 48.92%-1.39M | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 92.17%-6.23M | 72.22%-17.43M | -706.80%-10.32M | -9.20%-6.22M | 85.84%-1.38M | 3.92%-79.46M | -2.27%-62.75M | -152.55%-1.28M | 43.87%-5.7M | 28.58%-9.73M |
| Income tax | 672.81%2.64M | -592.50%-394K | -100.39%-1K | -133.33%-1K | -33.33%2K | 629.04%342K | 150.70%80K | 6,300.00%256K | -50.00%3K | -50.00%3K |
| Net income | 88.89%-8.87M | 72.89%-17.04M | -572.18%-10.32M | -9.12%-6.22M | 85.83%-1.38M | 3.56%-79.8M | -2.35%-62.83M | -163.17%-1.54M | 43.87%-5.7M | 28.59%-9.74M |
| Net income continuous operations | 88.89%-8.87M | 72.89%-17.04M | -572.18%-10.32M | -9.12%-6.22M | 85.83%-1.38M | 3.56%-79.8M | -2.35%-62.83M | -163.17%-1.54M | 43.87%-5.7M | 28.59%-9.74M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 88.89%-8.87M | 72.89%-17.04M | -572.18%-10.32M | -9.12%-6.22M | 85.83%-1.38M | 3.56%-79.8M | -2.35%-62.83M | -163.17%-1.54M | 43.87%-5.7M | 28.59%-9.74M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 88.89%-8.87M | 72.89%-17.04M | -572.18%-10.32M | -9.12%-6.22M | 85.83%-1.38M | 3.56%-79.8M | -2.35%-62.83M | -163.17%-1.54M | 43.87%-5.7M | 28.59%-9.74M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 88.96%-0.039 | 73.18%-0.0745 | 766.18%0.0453 | -8.70%-0.0275 | 85.91%-0.0061 | 14.64%-0.3534 | 9.22%-0.2778 | -156.67%-0.0068 | 50.39%-0.0253 | 37.25%-0.0433 |
| Diluted earnings per share | 88.96%-0.039 | 73.18%-0.0745 | -566.18%-0.0453 | -8.70%-0.0275 | 85.91%-0.0061 | 14.64%-0.3534 | 9.22%-0.2778 | -156.67%-0.0068 | 50.39%-0.0253 | 37.25%-0.0433 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.